CME Group Q3 revenue skyrockets 13% to $1.74 billion

• CME Group (NASDAQ:CME) reported third-quarter 2026 revenue of $1.74 billion, up 13% year over year, while adjusted diluted EPS of $3.02 exceeded analysts' $2.98 estimate.
• Average daily trading volume increased 16% to 29.4 million contracts, setting a third-quarter record, while market data revenue rose 20% to $243 million.
• CME returned approximately $989 million through dividends and repurchases, while its full-year adjusted operating expense outlook stood at approximately $1.695 billion, excluding license fees.

CME Group (NASDAQ:CME) reported third-quarter 2026 revenue of $1.74 billion, up 13% year over year from $1.54 billion, exceeding analysts' expectations of $1.71 billion.

Adjusted diluted earnings reached $3.02 per share, beating the $2.98 consensus estimate, while GAAP diluted EPS stood at $2.89, reflecting net income of approximately $1.04 billion.

Average daily volume increased 16% to a third-quarter record of 29.4 million contracts, with double-digit trading growth across all six asset classes.

Market data revenue climbed 20% to a record $243 million, while clearing and transaction fees generated approximately $1.4 billion during the quarter.

CME returned nearly $1 billion to shareholders, comprising $465 million in dividends and $524 million in share repurchases, while maintaining substantial cash reserves.

Shares declined approximately 2.4% in premarket trading despite the earnings beat, as investors assessed the company's operating expense outlook and future profitability.